Resolve BioSciences

Düsseldorf, Germany

Resolve Biosciences is a biotechnology research company for molecular cartography.

$71.0M raised

Oct 2022

Series B

Biotechnology Genetics Life Science Medical Neuroscience

Top Investors

HTGF (High-Tech Gruenderfonds)NRW.BANK Patient Square Capital EDBI Alafi Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Resolve BioSciences

How much funding has Resolve BioSciences raised?

Resolve BioSciences has raised $71.0M in total funding. The most recent round was Series B. The last funding was announced in October 2022.

Who are Resolve BioSciences's investors?

Resolve BioSciences's investors include HTGF (High-Tech Gruenderfonds), NRW.BANK, Patient Square Capital, EDBI, Alafi Capital.

Where is Resolve BioSciences headquartered?

Resolve BioSciences is headquartered in Düsseldorf, Germany.

What does Resolve BioSciences do?

Resolve Biosciences is a biotechnology research company for molecular cartography.

What stage is Resolve BioSciences at?

Resolve BioSciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2022.

MLA

"Resolve BioSciences — Funding & Investors." VCBacked, October 24, 2022, https://www.vcbacked.co/company/resolve-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2022). Resolve BioSciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/resolve-biosciences

Wikipedia (cite web)

{{cite web |title=Resolve BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/resolve-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K